Professor Giaccia joins the Department after many successful years as Director of the Division of Radiation & Cancer Biology at the University of Stanford, California. He is internationally recognised for his contribution to understanding the role of tumour microenvironment, hypoxia, and HIF-1-mediated pathways in cancer. He has more than 20 years of experience in his field of research with over 200 publications in addition to serving on a number of committees and editorial boards.
His international standing, plus his wealth of experience in the field of radiation oncology will ensure the continued success of OIRO and its close working relationships with cancer collaborators and major funding bodies. Professor Gavin Screaton, Head of the Medical Sciences Division, commented: ‘Amato is a fantastic catch for the Oxford oncology community and we are delighted he has chosen to join us from Stanford. He has already made his presence felt having hit the ground running and we look forward to him taking the Institute to the next level’.
Professor Mark Middleton, Head of the Department of Oncology, said: ‘The Department of Oncology is excited that Professor Giaccia has agreed to join us at such a momentous time to help us secure the future of OIRO and the contribution it makes to the world of radiation oncology’.
Dr Mariana Delfino-Machin, MRC Programme Manager for Cancer, said: ‘OIRO is the MRC’s major strategic investment in radiation oncology research and the appointment of Professor Giaccia provides a platform for OIRO to build upon its significant discoveries in the field. Professor Giaccia is an excellent addition to the UK’s radiation oncology community’.